Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 283

1.

The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial.

Abdalla S, Montez-Rath ME, Parfrey PS, Chertow GM.

Contemp Clin Trials. 2016 Apr 11;48:119-124. doi: 10.1016/j.cct.2016.04.001. [Epub ahead of print]

PMID:
27080930
2.

Analyzing Health-Related Quality of Life in the EVOLVE Trial: The Joint Impact of Treatment and Clinical Events.

Briggs AH, Parfrey PS, Khan N, Tseng S, Dehmel B, Kubo Y, Chertow GM, Belozeroff V.

Med Decis Making. 2016 Mar 17. pii: 0272989X16638312. [Epub ahead of print]

PMID:
26987347
3.

Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.

Hodgkinson KA, Howes AJ, Boland P, Shen XS, Stuckless S, Young TL, Curtis F, Collier A, Parfrey PS, Connors SP.

Circ Arrhythm Electrophysiol. 2016 Mar;9(3). pii: e003589. doi: 10.1161/CIRCEP.115.003589.

PMID:
26966288
4.

Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients.

Savio AJ, Daftary D, Dicks E, Buchanan DD, Parfrey PS, Young JP, Weisenberger D, Green RC, Gallinger S, McLaughlin JR, Knight JA, Bapat B.

BMC Cancer. 2016 Feb 17;16(1):113. doi: 10.1186/s12885-016-2149-9.

5.

Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial.

Belozeroff V, Chertow GM, Graham CN, Dehmel B, Parfrey PS, Briggs AH.

Value Health. 2015 Dec;18(8):1079-87. doi: 10.1016/j.jval.2015.08.007. Epub 2015 Oct 9.

PMID:
26686794
6.

Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis.

Parfrey PS, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Chertow GM.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):539-46. doi: 10.2215/CJN.06370615. Epub 2015 Nov 27.

PMID:
26614406
7.

Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

Pun PH, Abdalla S, Block GA, Chertow GM, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Goodman WG, Herzog CA, London GM, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Middleton JP.

Hemodial Int. 2015 Nov 13. doi: 10.1111/hdi.12382. [Epub ahead of print]

PMID:
26564024
8.

Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.

Lewis EF, Claggett B, Parfrey PS, Burdmann EA, McMurray JJ, Solomon SD, Levey AS, Ivanovich P, Eckardt KU, Kewalramani R, Toto R, Pfeffer MA.

Am Heart J. 2015 Aug;170(2):322-9. doi: 10.1016/j.ahj.2015.05.008. Epub 2015 May 22.

PMID:
26299230
9.

Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.

Kubo Y, Sterling LR, Parfrey PS, Gill K, Mahaffey KW, Gioni I, Trotman ML, Dehmel B, Chertow GM.

Pharm Stat. 2015 Jul-Aug;14(4):368. doi: 10.1002/pst.1694. Epub 2015 Jun 10. No abstract available.

PMID:
26096896
10.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*.

Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9.

PMID:
26059012
11.

The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial.

Chang TI, Abdalla S, London GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Dehmel B, Goodman WG, Chertow GM.

J Hum Hypertens. 2016 Mar;30(3):204-9. doi: 10.1038/jhh.2015.56. Epub 2015 Jun 4.

PMID:
26040438
12.

Psychometric properties of the Patient's Perception of Life on Hemodialysis Scale.

Twomey JC, Barrett BJ, Way CY, Churchill DN, Parfrey PS.

J Nurs Meas. 2015;23(1):72-81.

PMID:
25985496
13.

The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Floege J, Kubo Y, Floege A, Chertow GM, Parfrey PS.

Clin J Am Soc Nephrol. 2015 May 7;10(5):800-7. doi: 10.2215/CJN.10221014. Epub 2015 Apr 17.

14.

Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.

Kubo Y, Sterling LR, Parfrey PS, Gill K, Mahaffey KW, Gioni I, Trotman ML, Dehmel B, Chertow GM.

Pharm Stat. 2015 May-Jun;14(3):242-51. doi: 10.1002/pst.1680. Epub 2015 Apr 6. Erratum in: Pharm Stat. 2015 Jul-Aug;14(4):368.

PMID:
25851955
15.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.

16.

Clinical genetic research 1: Bias.

Stuckless S, Parfrey PS.

Methods Mol Biol. 2015;1281:333-48. doi: 10.1007/978-1-4939-2428-8_20.

PMID:
25694320
17.

Randomized controlled trials: planning, monitoring, and execution.

Hatfield E, Dicks E, Parfrey PS.

Methods Mol Biol. 2015;1281:273-86. doi: 10.1007/978-1-4939-2428-8_16.

PMID:
25694316
18.

Randomized controlled trials 7: Analysis and interpretation of quality-of-life scores.

Foley RN, Parfrey PS.

Methods Mol Biol. 2015;1281:261-72. doi: 10.1007/978-1-4939-2428-8_15.

PMID:
25694315
19.

Randomized controlled trials 6: On contamination and estimating the actual treatment effect.

Parfrey PS.

Methods Mol Biol. 2015;1281:249-59. doi: 10.1007/978-1-4939-2428-8_14.

PMID:
25694314
20.

Randomized controlled trials 1: Design.

Curtis BM, Barrett BJ, Parfrey PS.

Methods Mol Biol. 2015;1281:159-75. doi: 10.1007/978-1-4939-2428-8_9.

PMID:
25694309
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk